Low-density lipoprotein cholesterol reduction by SCH 58235 (ezetimibe), a novel inhibitor of intestinal cholesterol absorption in 243 hypercholesteremic subjects: Results of a dose-response study
- DOI
- 10.1016/s0021-9150(00)80603-6
- Published
- 2000-07
- Container
- Atherosclerosis
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/s0021-9150-00-80603-6,
title = {Low-density lipoprotein cholesterol reduction by SCH 58235 (ezetimibe), a novel inhibitor of intestinal cholesterol absorption in 243 hypercholesteremic subjects: Results of a dose-response study},
author = {H. Bays and M. Drehobl and S. Rosenblatt and P. Toth and C. Dujovne and R. Knopp and L. Lipka and C. Cuffie-Jackson},
year = {2000},
journal = {Atherosclerosis},
doi = {10.1016/s0021-9150(00)80603-6},
url = {https://doi.org/10.1016/s0021-9150(00)80603-6}
}RIS
TY - JOUR TI - Low-density lipoprotein cholesterol reduction by SCH 58235 (ezetimibe), a novel inhibitor of intestinal cholesterol absorption in 243 hypercholesteremic subjects: Results of a dose-response study AU - H. Bays AU - M. Drehobl AU - S. Rosenblatt AU - P. Toth AU - C. Dujovne AU - R. Knopp AU - L. Lipka AU - C. Cuffie-Jackson PY - 2000 JO - Atherosclerosis DO - 10.1016/s0021-9150(00)80603-6 UR - https://doi.org/10.1016/s0021-9150(00)80603-6 ER -
APA
Bays, H., Drehobl, M., Rosenblatt, S., Toth, P., Dujovne, C., Knopp, R., Lipka, L., & Cuffie-Jackson, C. (2000). Low-density lipoprotein cholesterol reduction by SCH 58235 (ezetimibe), a novel inhibitor of intestinal cholesterol absorption in 243 hypercholesteremic subjects: Results of a dose-response study. Atherosclerosis. https://doi.org/10.1016/s0021-9150(00)80603-6
Source records
- crossref · retrieved 2026-09-26T07:21:30.035Z